Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
New £1.5 million healthcare simulation facilities to open at Aston University
New clinical simulation facilities for medical, pharmacy and optometry students are set to open in 2022 Including an ocular simulation unit facility which will be the only one in Europe, as part of further investment in clinical facilities in the College of Health and Life Sciences at Aston University. The facilities are part funded by the Office for Students which awarded the University £806,226 to set up a ‘high fidelity’ simulation A&E room with further expenditure by Aston University on an ocular simulation unit. Aston Medical and Pharmacy School students will be able to practise in emergency settings using high quality manikins where they will simulate treating patients for acute conditions such as a heart attack or learning how to intubate a patient onto a ventilator. The high-fidelity acute care simulation room will be equipped with recording facilities, a debrief room and control room. The funding will allow for the purchase of other training equipment such as a hospital grade bed and single task trainer simulation equipment. For example, male and female catheterisation models, pelvic and rectal trainers, venepuncture arms, breast trainers and abdominal trainers. Professor Liz Moores, deputy dean of the College of Health and Life Sciences, said: “We are really excited to have the support from both the Office for Students and Aston University in building these state-of-the-art facilities for our students and can’t wait to start using them. “The acute care simulation room will allow us to simulate a variety of emergency resuscitation scenarios that are very difficult to teach in real life situations, such as heart attacks, acute breathlessness and severe allergic reaction and will be of great value in training students of medicine and pharmacy.” Students in the School of Optometry will also be equipped with simulation facilities to carry out treatment on patients. Professor James Wolffsohn, head of the School of Optometry said: “The ocular simulation facility at Aston University will be unique in Europe, allowing students to refine their skills in examining the health of the front and back of the eyes and to experience a wide range of eye disease. “One of the simulators even allows them to utilise their smartphone to practice at home. They can gain direct feedback and be assessed by the simulators, allowing more flexible, diverse and intensive learning than can be achieved with clinical practice placements.” It is hoped these facilities will help plug some of the gaps in clinical placements that are currently affecting students since the COVID-19 pandemic. As a result of the pandemic, alternative ways are being explored to gain high quality authentic ‘clinical’ experiences, whilst not exposing patients, staff, or students, to risk. The health crisis has also increased pressure on the NHS creating a need for alternative but appropriate training facilities, to ensure that students are fully prepared for the medical profession. The simulation facilities are due to be open in time for the September 2022 intake of students.
Aston University pharmacy graduate honoured for charity fundraising work
An Aston University pharmacy graduate has been recognised for his charitable fundraising in the Chemist and Druggist Awards 2021. Shoaib Hussain managed to raise thousands of pounds within just four weeks when he shared a video detailing his 2017 trip to help at Rohingya refugee camps in Bangladesh. He received the Above and Beyond Award at a ceremony held at the InterContinental London – The O2 on 19 November. Shoaib’s powerful video resonated so strongly with the public that he smashed his £25,000 fundraising target in just 24 hours. His campaign eventually raised £135,000 – all of which was donated to the charity Global Helping Hands, which is run by UK medical professionals. The money has paid for thousands of survival packs and the building of a medical centre, over 100 homes, 30 wells, and seven educational sites in Mosques. Shoaib said: “The video shared a personal account and was extremely difficult for me to voice. It detailed something I have not even spoken to my wife about fully, and something I still cannot talk about without tearing up when I remember what I witnessed.” Shoaib dedicated his award to “the refugees who I helped, and the donors who made it possible”.
Flavoured vapes less harmful to young people than smoking, could help teen smokers quit
Flavoured vapes are much less harmful to young people than smoking, and could help teen smokers quit tobacco – according to new research from the University of East Anglia. A new study published today looks at young peoples’ use of vape flavours, reporting the views and experiences of more than 500,000 under 18s. It finds that flavours are an important aspect of vaping that young people enjoy, suggesting that flavoured products may help them switch away from harmful tobacco smoking. But the researchers warn that more needs to be done to make sure that youngsters who have never smoked are not attracted to vaping. Lead researcher, Prof Caitlin Notley, from UEA’s Norwich Medical School, said: “There has been a lot of concern that young people may start vaping because they are attracted to e-liquid flavours, and that it could potentially lead them to start smoking tobacco. “We wanted to find out more about the links between vape flavours, the uptake of vaping among young people, and whether it leads to regular vaping and, potentially, tobacco smoking.” The research team studied all available evidence (58 studies) on young peoples’ use of e-liquid flavours. Prof Notley said: “We found that flavoured e-liquids are an important aspect of vaping that young people enjoy. This suggests that flavoured products may encourage young people to switch away from harmful tobacco smoking towards less harmful vaping. “Flavours may be an important motivator for e-cigarette uptake – but we found no evidence that using flavoured e-liquids attracted young people to go on to take up tobacco smoking. “And we also found no adverse effects or harm caused by using liquid vape flavours. “However, there is also a need to monitor flavour use to ensure that young people who have never smoked are not attracted to taking up vaping. “Ensuring the continued availability of a range of e-liquid flavours is likely to be important in encouraging young people who smoke to switch to vaping as a less harmful alternative,” she added. The team found that the overall quality of the evidence on use of e-cigarette flavours by young people was low. In particular, many studies did not clearly define e-liquid flavours and could not therefore be included within the review. The study was led by UEA in collaboration with researchers at University College London, the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust. ‘Youth Use of E-Liquid Flavours – A systematic review exploring patterns of use of e liquid flavours and associations with continued vaping, tobacco smoking uptake, or cessation’ is published in the journal Addiction on November 17, 2021.
With mask wearing and social distancing on the decline and the cold and flu season upon us, researchers have developed a viral panel that enables the simultaneous testing for SARS-CoV-2 along with numerous common respiratory viruses, that tells us whether other viruses also are at play in patients hard hit by COVID. This new genetic epidemiology tool that provides detailed genetic information about the viruses present when packaged with a molecular immunology model called Nextstrain also enables researchers to assess the novel viral variants that are circulating in a state or nation and patterns for their spread with the goal of helping predict and mitigate future outbreaks, says Dr. Ravindra Kolhe, director of the Georgia Esoteric and Molecular Laboratory, or GEM Lab, at the Medical College of Georgia at Augusta University. Deficits in SARS-CoV-2 monitoring and keeping tabs on other co-circulating respiratory viruses have been public health challenges during the pandemic, Kolhe and his colleagues report in the journal Viruses. Coinfection is a reality, Kolhe says with these respiratory viruses that we unwittingly transmit through the air when we cough, sneeze, even talk, particularly when we are in close quarters for long periods like hospitals, nursing homes, schools and potentially even our workplace. Another reality is that coinfections can have the compounding effect of worsening symptoms and outcomes, much as we have all heard that co-morbid conditions like diabetes and hypertension can do, he says. Particularly when patients are not doing well, looking for other respiratory viruses with the new panel could help provide insight on why and possibly new directions on how to help, he says. The more expansive panel is more expensive than straight COVID testing, which will remain the frontline test in this pandemic, Kolhe predicts. While the cold and flu season were essentially a wash last year because of COVID precautions like mask wearing — in fact the coinfection rate in the group they studied was under 1% — he and others are concerned the cold and flu season now upon us will be very different even with vaccination initiatives for both COVID and the flu. We’ve attached the full article – and it is well worth reading given the timing of flu season and another potential wave of COVID emerging globally. This is a fascinating topic and if you are a journalist covering the latest advancements in the effort to contain and eradicate COVID-19 – then let our leading experts help with your coverage and questions. Ravindra Kolhe is a Molecular and Genetic Pathologist, involved in identifying and validating cutting-edge platforms for diagnostic medicine. He’s also the Director of the Georgia Esoteric & Molecular Laboratory at Augusta University. If you are looking to arrange an interview with Dr. Kolhe – simply click on his icon now to find a time to talk today.
'Tangled Up' reveals science and history of Alzheimer's
A new book from leading University of East Anglia dementia expert Prof Michael Hornberger investigates the science and history of Alzheimer's disease. 'Tangled Up - The science and history of Alzheimer's disease' is available as a paperback or e-book. Prof Hornberger researches groups that are at higher risk of developing dementia (because of genetics, lifestyle or their other health condition) and works to help reduce this risk or delay the symptoms of dementia. He also explores the nature of support for those who have been diagnosed with dementia and helping the patients and their families and carers prepare for the future. His background is as a neuroscientist and his work involves using innovative techniques (such as online games and driver behaviour) to identify the spatial or navigation issues that can occur long before before diagnosis of dementia and before the traditional impacts on memory arise. He developed the mobile game Sea Hero Quest that can detect people at risk of Alzheimer's. His work enables early prediction of the likelihood of dementia (sometimes a decade ahead) and the opportunity to manage the onset and reduce risk by as much as 30 per cent. Prof Michael Hornberger, from UEA’s Norwich Medical School, said: “Alzheimer's disease is the most common cause of dementia in the UK. It affects around one in 14 people over the age of 65 and one in every six people over the age or 80 – and it can affect memory, thinking skills and other mental abilities. “I wanted to write a book to help people better understand the science and history of Alzheimer’s disease. “It covers everything from the causes of Alzheimer’s, through to why people with Alzheimer’s ‘live in the past’ and practical advice for how people can reduce the risk of developing it. “At the end of the book, you will have become an Alzheimer’s disease science expert and can use your newfound knowledge to untangle this devastating disease,” he added.
The health and safety of their children is the top priority of every parent. And after more than a year and a half of enduring a pandemic, mothers and fathers across America have been inundated with news, information and debate about what’s best for all of our health and how to avoid contracting COVID-19. And now, as America is seeing vaccines approved for children five and over, parents and the media are relying on leading experts to provide honest guidance, advice, and clarity on what parents need to know about what’s best for the health of America’s kids. It’s why Dr. Jody Terranova, a physician at UConn Health and the president-elect for the Connecticut chapter of the American Academy of Pediatrics, is getting the word out to parents: The state of Connecticut is already rolling out vaccinations for children ages five to eleven. This move comes on the heels of the CDC's formal recommended emergency use authorization. Within hours of the announcement, children here have rolled up their sleeves. One UConn School of Medicine pediatrician says she understands why parents have questions and hopes to clarify a few important details. Not only is Dr. Jody Terranova the president-elect for the Connecticut chapter of the American Academy of Pediatrics, she was also a member of the scientific sub-group of the state of Connecticut governor’s COVID-19 vaccine advisory group. “At this point, we are really recommending that all five to eleven-year-olds get vaccinated. There are very few children that should not get vaccinated right now," Dr. Terranova explained. Dr. Terranova admits the topic of vaccines for children ages five to eleven is a sensitive issue. That’s why in order to make an informed decision for your family, it's critical to ask important questions, like how does the vaccine work to protect the pediatric population from COVID-19? “The vaccine that we are giving for COVID works very similar to other vaccines, where it’s really activating your immune system to mount a response to recognize that virus when it invaded your body and create antibodies that will attack it so that it can’t replicate and infect you or your child," continued Dr. Terranova. November 4 - Eyewitness News If you are a journalist looking to know more about the COVID vaccine for children and the important information parents need to know, let us help with your coverage. Dr. Terranova is available to speak with media – simply click on her icon to arrange an interview today.
On Rethink What’s Possible, a podcast by Milwaukee School of Engineering, MSOE students, faculty, staff, alumni and community partners share their inventions, research, industry trends, projects, experiences and how they’re rethinking what's possible. Artificial intelligence. Machine learning. High performance computing. Super computers. These terms have been around for quite a while now, but only in recent years the research has been put into practice and there are no signs of it slowing down. Episode Three, 'Humanizing Machine Learning,' Artificial intelligence (AI) is becoming prominent in more and more industries each day, including health care. Artificial intelligence (AI) is becoming prominent in more and more industries each day, including health care. Join Dr. Sheila Ross and Dr. John Bukowy, AI faculty experts from Milwaukee School of Engineering (MSOE) and student Ethan Hindes as they discuss the advancements of AI in “Humanizing Machine Learning,” part of the MSOE podcast, “Rethink What’s Possible.” They talk about its impact on their research with the Medical College of Wisconsin to identify and assess the severity of damage to blood vessels in kidneys. Hindes also discusses how he found his way to major in computer science. The podcast is available for download and well worth listening to. And, if you are a journalist interested in learning more or arranging an interview with Dr. Ross or Bukowy – simply click on either expert's icon now to arrange an interview today.
Ray A. Blackwell, M.D., MJ, chief of Cardiac Surgery and the W. Samuel Carpenter, III, Distinguished Chair of Cardiovascular Surgery at ChristianaCare, received the 2021 Tilton Award from the Medical Society of Delaware on Oct. 28 at the Tilton Mansion, now the University & Whist Club in Wilmington, Del. The award recognizes Dr. Blackwell as a pre-eminent cardiac surgeon the past 21 years and for his life-long commitment to service for the betterment of patients, the local community and the nation. The award is named for James Tilton, M.D., the first U.S. Army Surgeon General of the United States and the first president of the Medical Society of Delaware. “Dr. Blackwell is an outstanding choice for this prestigious award,” said Kirk Garratt, M.D., medical director of ChristianaCare’s Center for Heart & Vascular Health. “He has given a great deal to his patients, his colleagues and his profession. His strong leadership and clinical expertise have led to optimal health and an exceptional experience for many patients in our community. In addition to being an excellent surgeon, Dr. Blackwell has been dedicated to driving innovations that improve patient outcomes and has been committed to finding ways of keeping patients healthy and preventing cardiovascular disease.” Since joining ChristianaCare in 1996, Dr. Blackwell has been recognized among the top cardiac physicians in our region and has been instrumental to the development of the cardiac surgery program. In 2011, he became the surgical director of the Mechanical Circulatory Support Program and led the initiative to establish Christiana Care’s Ventricular Assist Device Program. In 2017 he was named Chief of Cardiac Surgery and has since led the health system’s team of highly skilled and experienced heart surgeons who perform more than 700 heart surgeries each year. Dr. Blackwell is a clinical assistant professor of Surgery at Sidney Kimmel Medical College of Thomas Jefferson University. He served as the chair of ChristianaCare’s Blood Pressure Ambassador Advisory Committee. Dr. Blackwell has dedicated his life to service of others, especially on behalf of underprivileged and underrepresented people. As a high school student, he participated in A Better Chance Program, which places underprivileged, underrepresented and underfunded students in better academic environments. He is still active with the organization. He also served on the minority admissions subcommittee and later became a regional recruiter for Dartmouth College and Dartmouth Medical School. In 2019, he received a lifetime achievement award as part of a Dartmouth College celebration, “Standing at the Threshold,” honoring Dr. Martin Luther King Jr. Dr. Blackwell also received the Raising Kings award in 2018 from the One Village Alliance, an agency dedicated to elevating positive images and setting high expectations for Wilmington’s Black men and boys, He is a regional alumni council member of National Medical Fellowships, which funds underrepresented and underfunded medical students and is co-founder of the Association of Black Cardiovascular and Thoracic Surgeons, which supports and develops upcoming and practicing cardiothoracic surgeons. He has also held numerous leadership board positions for Delaware organizations, including the Delaware Medical Education Foundation, the Delaware Board of Medical Licensure and Discipline, the New Castle County and Great Rivers Affiliate Boards of Directors for the American Heart Association. He is also a board member of the Friends of Hockessin Colored School 107C and Indoor Track Delaware. Dr. Blackwell is also a recipient of the James H. Gilliam, Jr. Award from the American Heart Association for his contributions to the health, welfare and benefit of the community.
MEDIA RELEASE: Ten things Ontarians need to know prior to booking travel abroad
CAA South Central Ontario (CAA SCO) has compiled a list of ten things that Ontarians should be aware of if they are considering travelling abroad. “Now that the Canadian government is no longer advising against non-essential travel due to COVID-19, those who are considering booking a trip should make sure they understand the scope of what travel looks like at the moment,” said Kaitlynn Furse, director, corporate communications, CAA Club Group. “The checklist for planning a trip has changed and we want to help people navigate this new environment.” Through consultation with its top travel agents, CAA SCO has identified ten key considerations that potential travellers may not be aware of. Anyone who is considering travel in the current environment should make sure they have looked into the following and remember that travel requirements and regulations are continually changing. 1. Confirm the COVID-19 situation at destination prior to booking. Understand the risk level associated with travel to a particular destination by checking the Government of Canada Travel Advice and Advisories website. While the Global Affairs Canada Level 3 Travel Advisory to avoid all non-essential travel has been lifted, individual travel advisories do remain on a country-by-country basis. It is important that Canadians understand the ongoing uncertainty associated with international travel, whether that be related to the continued community transmission of COVID-19, or state of health care systems in destinations hit hard by the pandemic. 2. Understand the type, timing, cost and accessibility of required COVID testing. Every country has different requirements when it comes to the COVID tests that are needed prior to travel, and every country has different testing capacities once you are there. There are also requirements in order to return to Canada. Make sure you understand the difference between molecular PCR and rapid antigen tests, in what time period tests must be taken, the associated costs and locations where these tests are available. 3. Confirm change and cancellation flexibility with your travel service provider. Many airlines and hotels have been providing more flexibility when it comes to refunds and changes to bookings. Make sure you understand any key dates related to cancellation and changes and whether you are entitled to a refund or a future travel voucher or credit at the time of booking. 4. Buy travel insurance and understand what is covered. Make sure you have $5 million in coverage for emergency medical situations and that illness related to COVID-19 is included. Understand your entitlements for things like denied boarding in the event of a positive test and coverage related to isolation expenses. 5. Prepare required travel documentation and the format it must be presented in, for both Canada and your destination. Canadians returning home should have all required documentation loaded onto the ArriveCAN App or website. Each destination has varying requirements, so make sure you fully understand what information you need to have ready and in what format. Make sure you also take into consideration connections and any requirements in the connecting destination due to lay over or delays. 6. Take note of local public health rules prior to departure. Many destinations have measures in place such as curfews and quarantine requirements. You should also understand what the regulations are if you happen to test positive for COVID-19 in the country you are visiting. 7. Be aware of changes between booking and departure. Make sure you reconfirm all the details that were researched prior to booking, to ensure they are still accurate prior to departure. What was true when a trip was booked may not be the case by the time you are ready to travel. 8. Double check all research with the appropriate embassy or consulate. Travel at this time is complex and many factors can change quickly, so ensuring you have the most up to date and accurate information is essential. 9. Plan for extra time. From disembarkment and customs to retrieving luggage and exiting the airport, most things on the travel journey are taking longer than during pre-COVID travel times. Also note the check-in and baggage drop off deadline for your flight as it may require you to arrive earlier than anticipated. 10. Stay connected. Fully unplugging while travelling is likely a thing of the past. It is important to have access to trusted, up-to-date information while travelling so you can monitor changing conditions and requirements and adapt accordingly. Bookmark the Global Affairs Canada website prior to departure and check it regularly while abroad. It is also a good idea to sign up for Registration of Canadians Abroad and stay in touch with a family or friend that has knowledge of your travel plans.
Could Vitamin-A bring back your sense of smell after Covid?
Researchers at the University of East Anglia and James Paget University Hospital are launching a new project to see whether Vitamin A could help people regain their sense of smell after viral infections including Covid-19. Smell loss is a common symptom of Covid-19, but even before Covid, many viruses had been causing smell loss and distortion and while most people naturally regain their sense of smell within a couple of weeks, many have been left with on-going smell disorders. Previous research from Germany has shown the potential benefit of Vitamin-A, and the UEA team will explore how this treatment works to help repair tissues in the nose damaged by viruses. They hope that the study, which has been funded by the National Institute for Health Research (NIHR), could one-day help improve the lives of millions around the world who suffer from smell loss, by returning their fifth sense. Smell loss expert Prof Carl Philpott from UEA’s Norwich Medical School and James Paget University Hospitals NHS Trust, said: “The huge rise in smell loss caused by Covid-19 has created an unprecedented worldwide demand for treatment. “Even before the Covid-19 pandemic hit, smell loss was thought to affect an estimated five per cent of people, with viruses accounting for 1 in 10 of those. “And around one in ten people who experience smell loss as a result of Covid-19 report that their sense of smell has not returned to normal four weeks after falling ill. “It’s a big problem, and our previous research has shown the impact of smell loss – including depression, anxiety and isolation, as well as risk of danger from hazards such as gas and spoiled food, and changes in weight due to reduced appetite. “A key problem for patients and their clinicians is the lack of proven effective treatments. “A recent study from Germany showed that people treated with vitamin A nasal drops improved twice as much as those in the untreated group. “We want to find out whether there is an increase in the size and activity of damaged smell pathways in patients’ brains when they are treated with vitamin A nasal drops. “This would show recovery of the damage caused by common viral infections, including Covid-19, in the nose.” The research team will work with patients who have lost their sense of smell due to a viral infection. They will either receive a 12-week course of nasal vitamin A drops or inactive equivalent drops, and have their brains scanned before and after the treatment. The scans will be compared to those of a control group who have not been treated with vitamin A drops. Prof Philpott said: “The patients will be smelling distinctive odours - roses and rotten eggs - while special MRI brain scans are taken. “We will look for changes in the size of the olfactory bulb - an area above the nose where the smell nerves join together and connect to the brain. “We will also look at activity in areas of the brain linked to recognising smells,” he added. Duncan Boak, Founder and Chair of Fifth Sense, said: “At Fifth Sense we have engaged with thousands of people who have experienced changes in their ability to smell or taste as a result of the Covid 19 virus. They join an already large community of people with a smell disorder that pre-dates the pandemic. “The question we are most often asked is about available treatments to support recovery. Not being able to smell is not only physically distressing but can affect the enjoyment of social occasions and present hazards and risks that might never have been previously considered such as not being able to detect gas leaks or spoiled food. “Research into potentially successful interventions is vital to help people feeling the impact of smell disorders that affects the quality and enjoyment of their life.” To take part in this trial, patients need to be referred to The Smell and Taste Clinic at the James Paget University Hospital by their GP. Recruitment is expected to begin in December 2021. To find out more visit https://rhinology-group.uea.ac.uk/apollo-trial or contact apollo.trial@uea.ac.uk. The NIHR is the largest funder of research in the country, and is the research partner of the NHS and social care. To find out more about other NIHR research happening near you, visit www.bepartofresearch.uk.